Pharmavite Amends CholestOff Claims After FTC Joins Heart Health Hunt
This article was originally published in The Tan Sheet
Executive Summary
An attorney for Pharmavite questions federal regulators' apparent pursuit of cholesterol-lowering products after the firm satisfies a Federal Trade Commission investigation by revising marketing language for its CholestOff dietary supplement